Your search returned 530 results.

Results
	441.	A phase 1/2 study of oral panobinostat combined with melphalan for patients with relapsed or refractory multiple myeloma. [electronic resource] by Berenson, James R Hilger, James D Yellin, Ori Boccia, Ralph V Matous, Jeffrey Dressler, Kenneth Ghazal, Hassan H Jamshed, Saad Kingsley, Edwin C Harb, Wael A Noga, Stephen J Nassir, Youram Swift, Regina A Vescio, Robert Producer: 20140226 In: Annals of hematology vol. 93 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	442.	Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways. [electronic resource] by Bruzzese, F Pucci, B Milone, M R Ciardiello, C Franco, R Chianese, M I Rocco, M Di Gennaro, E Leone, A Luciano, A Arra, C Santini, D Caraglia, M Budillon, A Producer: 20140312 In: Cell death & disease vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	443.	GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3. [electronic resource] by Fabian, Johannes Lodrini, Marco Oehme, Ina Schier, Marie C Thole, Theresa M Hielscher, Thomas Kopp-Schneider, Annette Opitz, Lennart Capper, David von Deimling, Andreas Wiegand, Inga Milde, Till Mahlknecht, Ulrich Westermann, Frank Popanda, Odilia Roels, Frederik Hero, Barbara Berthold, Frank Fischer, Matthias Kulozik, Andreas E Witt, Olaf Deubzer, Hedwig E Producer: 20140706 In: Cancer research vol. 74 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	444.	The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity. [electronic resource] by Woods, David M Woan, Karrune Cheng, Fengdong Wang, Hongwei Perez-Villarroel, Patricio Lee, Calvin Lienlaf, Maritza Atadja, Peter Seto, Edward Weber, Jeffrey Sotomayor, Eduardo M Villagra, Alejandro Producer: 20151215 In: Melanoma research vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	445.	Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin. [electronic resource] by Kai, Masaya Kanaya, Noriko Wu, Shang V Mendez, Carlos Nguyen, Duc Luu, Thehang Chen, Shiuan Producer: 20160204 In: Breast cancer research and treatment vol. 151 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	446.	Epigenetic modifiers upregulate MHC II and impede ovarian cancer tumor growth. [electronic resource] by Turner, Taylor B Meza-Perez, Selene Londoño, Angelina Katre, Ashwini Peabody, Jacelyn E Smith, Haller J Forero, Andres Norian, Lyse A Straughn, J Michael Buchsbaum, Donald J Randall, Troy D Arend, Rebecca C Producer: 20180406 In: Oncotarget vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	447.	NICE guidance on panobinostat for patients with multiple myeloma after at least two previous treatments. [electronic resource] by Hall, Caroline J Doss, Sally Hay, Nicola Sutcliffe, Frances Stevens, Andrew Producer: 20160801 In: The Lancet. Oncology vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	448.	Short Communication: The Broad-Spectrum Histone Deacetylase Inhibitors Vorinostat and Panobinostat Activate Latent HIV in CD4(+) T Cells In Part Through Phosphorylation of the T-Loop of the CDK9 Subunit of P-TEFb. [electronic resource] by Jamaluddin, Md Saha Hu, Pei-Wen Jan, Yih Siwak, Edward B Rice, Andrew P Producer: 20161213 In: AIDS research and human retroviruses vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	449.	A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer. [electronic resource] by Rathkopf, Dana Wong, Bryan Y Ross, Robert W Anand, Aseem Tanaka, Erika Woo, Margaret M Hu, Jing Dzik-Jurasz, Andy Yang, Wei Scher, Howard I Producer: 20100506 In: Cancer chemotherapy and pharmacology vol. 66 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	450.	Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib. [electronic resource] by Lachenmayer, Anja Toffanin, Sara Cabellos, Laia Alsinet, Clara Hoshida, Yujin Villanueva, Augusto Minguez, Beatriz Tsai, Hung-Wen Ward, Stephen C Thung, Swan Friedman, Scott L Llovet, Josep M Producer: 20120917 In: Journal of hepatology vol. 56 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	451.	Sustained inhibition of deacetylases is required for the antitumor activity of the histone deactylase inhibitors panobinostat and vorinostat in models of colorectal cancer. [electronic resource] by Wilson, Peter M Labonte, Melissa J Martin, Shelby C Kuwahara, Stephanie T El-Khoueiry, Anthony Lenz, Heinz-Josef Ladner, Robert D Producer: 20140211 In: Investigational new drugs vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	452.	Antitumor activities and on-target toxicities mediated by a TRAIL receptor agonist following cotreatment with panobinostat. [electronic resource] by Martin, Ben P Frew, Ailsa J Bots, Michael Fox, Stephen Long, Fenella Takeda, Kazuyoshi Yagita, Hideo Atadja, Peter Smyth, Mark J Johnstone, Ricky W Producer: 20110609 In: International journal of cancer vol. 128 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	453.	Low dose histone deacetylase inhibitor, LBH589, potentiates anticancer effect of docetaxel in epithelial ovarian cancer via PI3K/Akt pathway in vitro. [electronic resource] by Chao, Hongtu Wang, Li Hao, Jingli Ni, Jie Chang, Lei Graham, Peter H Kearsley, John H Li, Yong Producer: 20130424 In: Cancer letters vol. 329 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	454.	Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3. [electronic resource] by Lai, F Guo, S T Jin, L Jiang, C C Wang, C Y Croft, A Chi, M N Tseng, H-Y Farrelly, M Atmadibrata, B Norman, J Liu, T Hersey, P Zhang, X D Producer: 20140225 In: Cell death & disease vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	455.	In vivo monitoring of the anti-angiogenic therapeutic effect of the pan-deacetylase inhibitor panobinostat by small animal PET in a mouse model of gastrointestinal cancers. [electronic resource] by Maschauer, Simone Gahr, Susanne Gandesiri, Muktheshwar Tripal, Philipp Schneider-Stock, Regine Kuwert, Torsten Ocker, Matthias Prante, Olaf Producer: 20160926 In: Nuclear medicine and biology vol. 43 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	456.	Simvastatin functions as a heat shock protein 90 inhibitor against triple-negative breast cancer. [electronic resource] by Kou, Xinhui Jiang, Xiaoxiao Liu, Huijuan Wang, Xuan Sun, Fanghui Han, Jiami Fan, Jiaxing Feng, Guize Lin, Zhaohu Jiang, Lan Yang, Yonghua Producer: 20181012 In: Cancer science vol. 109 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	457.	HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA). [electronic resource] by Mehdi, Ouaïssi Françoise, Silvy Sofia, Costa Lima Urs, Giger Kevin, Zemmour Bernard, Sastre Igor, Sielezneff Anabela, Cordeiro-da-Silva Dominique, Lombardo Eric, Mas Ali, Ouaïssi Producer: 20121120 In: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	458.	LBH-589 (panobinostat) potentiates fludarabine anti-leukemic activity through a JNK- and XIAP-dependent mechanism. [electronic resource] by Rosato, Roberto Hock, Stefanie Dent, Paul Dai, Yun Grant, Steven Producer: 20120411 In: Leukemia research vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	459.	Cellular determinants for preclinical activity of a novel CD33/CD3 bispecific T-cell engager (BiTE) antibody, AMG 330, against human AML. [electronic resource] by Laszlo, George S Gudgeon, Chelsea J Harrington, Kimberly H Dell'Aringa, Justine Newhall, Kathryn J Means, Gary D Sinclair, Angus M Kischel, Roman Frankel, Stanley R Walter, Roland B Producer: 20140319 In: Blood vol. 123 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	460.	Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide). [electronic resource] by Xia, Chang Leon-Ferre, Roberto Laux, Douglas Deutsch, Jeremy Smith, Brian J Frees, Melanie Milhem, Mohammed Producer: 20150220 In: Cancer chemotherapy and pharmacology vol. 74 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
14
15
16
17
18
19
20
21
22
23
24
25
26
27
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 530 results.